What is Fiasp?
Fiasp (insulin aspart) is a rapid-acting insulin analogue used in the management of diabetes mellitus. It works by replacing or supplementing endogenous insulin production, helping to regulate blood glucose levels following meals and throughout the day. Fiasp has a fast onset of action within 15 minutes after administration and reaches its peak effect within 1 hour, lasting for approximately 2-4 hours. It is used in conjunction with diet and exercise in patients with diabetes, both type 1 and type 2, to improve glycemic control and prevent complications associated with hyperglycemia.
What is Fiasp used for?
Fiasp, also known as insulin aspart, is a fast-acting insulin analog used in the treatment of diabetes mellitus type 1 and type 2. It is a rapid-acting insulin that starts to work within 15 minutes after injection, peaks in about an hour, and continues to work for approximately three to four hours. Fiasp is a recombinant human insulin analog produced by yeast fermentation with genetic modification. Its primary use is as an adjunct to diet and exercise to improve glycemic control in people with diabetes.
Fiasp contains the same active ingredient as other fast-acting insulins but has some distinct characteristics, such as a faster onset of action and a more rapid return to baseline glucose levels. It is typically administered via subcutaneous injection one to 30 minutes before meals to help manage postprandial blood glucose spikes. Fiasp can be used in various situations, including premeal insulin therapy, postmeal corrections for high blood glucose, or as part of an insulin pump regimen. Its formulation includes a modified amino acid sequence that allows it to dissociate more quickly from the alpha subunit after injection, leading to a faster onset of action compared to traditional human insulins.
Precautions and potential side effects should be considered when using Fiasp, including the risk of hypoglycemia (especially in combination with other insulin or oral antidiabetic agents), increased risk of lipodystrophy if reused injection sites repeatedly over a long period, and rare instances of anaphylaxis.
Fiasp side effects
- Injection site reactions
- Hypoglycemia
- Allergic reactions
- Nausea and vomiting
- Headache
- Fatigue
- Dizziness
- Muscle pain
- Chills
- Skin rash
- Abdominal discomfort
- Injection site edema
Disclaimer
The content on this website is for informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. The information provided here is based on general research and may not apply to individual circumstances. We do not guarantee the accuracy or completeness of any content on this website. Always consult with a healthcare professional before making any changes to your medication or health routine.